Overview
Astrid Zimmermann practices in Darmstadt, Germany. Ms. Zimmermann is rated as an Elite expert by MediFind in the treatment of Ataxia-Telangiectasia. Her top areas of expertise are Ataxia-Telangiectasia, Telangiectasia, Drug Induced Dyskinesia, and Lung Cancer.
Her clinical research consists of co-authoring 31 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 3 articles in the study of Ataxia-Telangiectasia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Ataxia-TelangiectasiaMs. Zimmermann isElite. Learn about Ataxia-Telangiectasia.
- Distinguished
- TelangiectasiaMs. Zimmermann isDistinguished. Learn about Telangiectasia.
- Advanced
- Drug Induced DyskinesiaMs. Zimmermann isAdvanced. Learn about Drug Induced Dyskinesia.
- Experienced
- Breast CancerMs. Zimmermann isExperienced. Learn about Breast Cancer.
- Desmoplastic Small Round Cell TumorMs. Zimmermann isExperienced. Learn about Desmoplastic Small Round Cell Tumor.
- Hepatocerebral DegenerationMs. Zimmermann isExperienced. Learn about Hepatocerebral Degeneration.
- LeukemiaMs. Zimmermann isExperienced. Learn about Leukemia.
- Lung CancerMs. Zimmermann isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Ms. Zimmermann isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).